Tizanidine
Product Images NDC 50436-6756

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Tizanidine (NDC 50436-6756). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Unit Dose Services, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fig1 (Fig1)

A pharmacokinetic line graph showing plasma tizanidine concentration (ng/mL) over time (hours) from dosing. Four conditions are compared: 2 x 4 mg tizanidine tablets with food, without food, and 2 x 4 mg tizanidine capsules with and without food. The graph illustrates concentration changes up to 24 hours after dosing.*

FDA Label Image

Fig2 (Fig2)

A line graph showing improvement in Ashworth Score over time (hours post-dose) for Tizanidine at 8 mg and 16 mg doses compared to placebo. The y-axis represents improvement in Ashworth Score, and the x-axis shows hours post-dose from 0 to 6. Error bars indicate variability at each time point.*

FDA Label Image

Fig3 (Fig3)

This line plot compares improvement in Ashworth Score between Tizanidine (mean dose 28.8 mg) and placebo groups measured at three time points: end of titration (study week 3), end of maintenance (study week 7), and endpoint (last observation carried forward). Tizanidine shows greater improvement with error bars indicating variability at each time point.*

FDA Label Image

Label Image (Lbl504366756)

Packaging label for Tizanidine Hydrochloride 4 mg tablets, containing 30 tablets per package. Manufactured by Dr. Reddy's Labs Ltd in India. Label includes NDC 50436-6756-1, tablet strength, active ingredient equivalence, storage instructions, and lot/expiration date placeholders. The package is distributed by Unit Dose Services, LLC, Florida. The product is labeled for prescription use only (RX ONLY).*

FDA Label Image

Structure (Structure)

Chemical structure diagram of the active ingredient tizanidine hydrochloride, showing its molecular framework with fused rings and functional groups as depicted.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.